The concept of a patent lies at the heart of intellectual property law. A patent grants an inventor the exclusive right to produce, use, sell or license an invention for a limited period. This monopoly exists not merely to reward the inventor but to encourage public disclosure of knowledge and foster societal progress. One of the most important dimensions of this protection is its duration. Patent laws around the world recognise that such exclusivity cannot be perpetual. The patent term therefore functions as a carefully calibrated period during which the inventor enjoys a temporary monopoly, after which the invention enters the public domain. Determining how long patents last, the factors that affect the term, and the legal framework that governs extensions, lapses and revivals, are all crucial elements for businesses, research institutions, start-ups and legal professionals.

I. Legislative Framework in India

The duration of a patent in India is governed primarily by the Patents Act, 1970. Section 53 of the Act provides the general rule that the term of every patent in India is twenty years, counted from the date of filing the application. This twenty-year term applies uniformly to all categories of inventions, including pharmaceuticals, biotechnology, mechanical inventions, chemical compositions, software-related innovations and process patents. For Patent Cooperation Treaty (PCT) applications, the twenty-year term is calculated from the international filing date.

The transition to the uniform twenty-year term occurred as part of India’s compliance with the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement), which mandates a minimum patent term of twenty years. Prior to the Patents (Amendment) Act, 2002, process patents in pharmaceuticals and agro-chemicals were granted for seven years, but the amendment harmonised India’s law with global standards.

Thus, under the current legal regime, the twenty-year term is absolute, subject only to statutory provisions relating to lapses due to non-payment of renewal fees, restoration of lapsed patents and specific exclusions such as patents of addition.

II. Commencement of Patent Term

Understanding when the patent term begins is central to calculating its end. Under Section 45 of the Patents Act, 1970, a patent becomes effective from the date it is granted. However, the term under Section 53 is calculated from the date of filing, not the date of grant. This means that the effective period of enforceable rights may be shorter than twenty years in cases where the examination process is prolonged.

For example, if a patent application filed in 2024 is granted in 2030 due to delays, the term still expires in 2044, not 2050. This contrasts with certain jurisdictions, such as the United States, where the term is also twenty years but may include patent term adjustments compensating for delays caused by the patent office. Indian law currently does not provide patent term extensions except for specific situations involving pharmaceutical products and agro-chemical products under certain international commitments.

III. Renewal Fees and Lapse of Patent Term

While the statutory term is twenty years, continuation of the patent for the entire duration depends on payment of annual renewal fees. Under Sections 142 and 143 of the Act, renewal fees must be paid every year starting from the third year until the twentieth year. Failure to pay renewal fees results in the lapse of the patent, meaning the exclusivity is extinguished.

However, Section 60 allows the patentee to apply for restoration of a lapsed patent within eighteen months from the date of lapse. The patentee must show that non-payment of renewal fees was unintentional and must satisfy the Controller. If restored, the patent resumes its enforceability, although any rights gained by third parties during the period of lapse may be protected under Section 62.

IV. Term of Patents of Addition

Patents of addition are addressed in Sections 54 to 56. A patent of addition is granted for improvements or modifications of an already patented invention. The term for a patent of addition does not exceed the term of the main patent. Therefore, if the main patent expires on a particular date, the patent of addition expires concurrently. No separate renewal fee is required for a patent of addition unless it is converted into an independent patent.

V. Patent Term Under the TRIPS Agreement

International patent law significantly influences India’s domestic patent regime. Under Article 33 of the TRIPS Agreement, the term of protection available shall not end before twenty years counted from the filing date. This has harmonised patent terms across the globe and has strengthened protection for innovators engaged in international business, cross-border licensing and global research collaborations.

India’s shift from shorter terms for certain inventions to the uniform twenty-year term was primarily driven by the need to comply with TRIPS, ensuring that inventors in sectors such as pharmaceuticals, biotechnology and software-related inventions receive global competitiveness and certainty.

VI. Extensions or Adjustments of Patent Term

Unlike jurisdictions such as the United States, Japan or the European Union, the Indian patent law does not provide patent term extensions for delays in regulatory approval or examination by the patent office. However, under international obligations and domestic policy discussions, some limited exceptions exist.

For example, the Product Patent regime under the Patents (Amendment) Act, 2005 brought India into compliance with TRIPS by permitting pharmaceutical product patents. However, unlike certain other nations, India does not offer extended exclusivity even for pharmaceutical products facing long drug-approval processes. This position was upheld to maintain a balance between incentivising innovation and ensuring affordable access to essential medicines.

VII. Judicial Approach on Patent Term and Public Interest

Indian courts have repeatedly emphasised that a patent is a time-bound monopoly granted in exchange for full disclosure of the invention. The judiciary recognises the delicate balance between the rights of inventors and the greater public interest.

1. Novartis AG v. Union of India (2013)

In this landmark case, the Supreme Court reaffirmed the strict standards of patentability for pharmaceutical inventions under Section 3(d). Although the case did not directly concern patent term, it underscored the importance of limiting the monopoly period to prevent “evergreening” of patents. Evergreening refers to attempts by patentees to extend the term of their exclusivity by filing marginal modifications or incremental innovations. The Court stressed that the twenty-year term must not be manipulated or extended through trivial patents of addition or secondary patents.

2. Merck Sharp and Dohme Corp. v. Glenmark Pharmaceuticals (2015)

In this Delhi High Court judgment involving the anti-diabetic drug Sitagliptin, the Court emphasised that patent rights are enforceable only during the valid term of the patent. The case reaffirmed that once the patent term expires, the invention falls into the public domain, allowing generic manufacturers to enter the market freely.

3. Enercon (India) Limited v. Aloys Wobben (2014)

This Supreme Court decision highlighted procedural issues relating to patent validity but also reiterated the principle that patent rights exist strictly within the statutory term and cannot be exercised thereafter.

4. Bayer Corporation v. Union of India (2014)

In this case involving the cancer drug Nexavar, the Delhi High Court upheld the grant of a compulsory licence. Though the core issue was pricing and public access, the Court underlined that the twenty-year patent term balances the inventor’s rights with public health needs. The case illustrates how the limited monopoly period is treated as carefully calibrated and rarely interfered with through judicial intervention.

VIII. Impact of Patent Term on Industries and Innovation

The duration of patent rights has far-reaching implications for different industries.

1. Pharmaceuticals and Biotechnology

These industries are particularly affected because drug development involves long research cycles and time-consuming regulatory approval processes. Although the twenty-year patent term begins from the filing date, the effective period of commercial enjoyment may be much shorter. This has been a significant policy concern globally. However, India maintains a policy stance that prioritises public health and affordable access, rejecting broad patent term extensions.

2. Technology and Software-Driven Industries

Inventions in software-related domains, artificial intelligence, and electronics often face rapid technological obsolescence. For such industries, the twenty-year term may have diminishing value in later years. Nevertheless, the uniform term offers predictability and encourages investment in research.

3. Agriculture and Chemical Formulations

Patents relating to fertilisers, pesticides, seeds and chemical compositions rely on predictable patent terms for commercial planning and licensing. The expiry of these patents often leads to significant price reductions and greater availability of products.

IX. Expiry of Patent Term and Transition to Public Domain

At the end of the twenty-year term, all rights under the patent cease. The invention becomes part of the public domain and may be freely manufactured, used or sold by anyone. This transition is fundamental to the philosophy of patent law.

Indian courts have consistently held that after expiry, no exclusive rights can be claimed, regardless of whether the invention continues to generate commercial value. This principle was highlighted in Merck v. Glenmark, where the court noted that generics are free to manufacture the drug upon expiry without fear of infringement.

The public domain status also encourages further research, reverse engineering, and development of improved products. For instance, the expiry of patents in the telecommunications industry enables the creation of compatible and standardised technologies that can be used globally.

X. Restoration After Expiry due to Lapse

If a patent lapses due to non-payment of renewal fees, restoration is possible under Section 60. This provision is not an extension of the patent term but merely reinstates the rights that would have existed had the patent remained in force. Courts have observed that restoration cannot be used to extend the patent beyond the statutory twenty years. The restoration must be applied for within the prescribed period and justified on the grounds of unintentional lapse.

XI. Patent Term in Comparison with Other Jurisdictions

Although the article focuses on Indian law, an understanding of international approaches helps situate India’s policy choices.

1. United States

Patent terms are also twenty years from the date of filing. However, the US system includes Patent Term Adjustment (PTA) and Patent Term Extension (PTE) mechanisms for delays attributable to the Patent Office or regulatory bodies like the FDA.

2. European Union

The EU provides a twenty-year term, with the possibility of Supplementary Protection Certificates (SPCs) adding up to five years for pharmaceutical and plant protection products.

3. Japan and South Korea

Similar extension mechanisms exist to compensate for regulatory delays.

India’s refusal to adopt extensions stems from public policy priorities, especially in relation to essential medicines and technology access.

XII. Policy Debates Surrounding Patent Term

The debate around patent term continues in policy circles. Supporters of patent term extensions argue that:

1. Drug development timelines have increased significantly.
2. Complex regulatory approvals reduce the effective period of commercial exclusivity.
3. Strong patent protection promotes foreign investment and innovation.

Critics argue that:

1. Extensions would delay entry of cheaper generics.
2. Public health would be compromised in a country where affordability is key.
3. Over-protection stifles competition and leads to monopolistic pricing.

India’s current stance attempts to balance innovation with accessibility, keeping the twenty-year term fixed while ensuring strict standards of patentability.

Conclusion

The patent term is one of the most significant components of patent law because it defines the temporal boundary of an inventor’s exclusive rights. Under Indian law, the term of every patent is twenty years from the filing date, subject to renewal fees, restoration provisions and statutory exceptions. Indian courts have consistently upheld the limited nature of patent monopolies and have resisted attempts to extend or evergreen patents. This approach aligns with India’s commitment to public welfare, competitive markets and affordable access to essential technologies.

Understanding the duration of patent rights is vital for inventors, businesses, researchers and policymakers. The expiry of patent rights, though it marks the end of exclusive control, contributes to the wider cycle of innovation by allowing inventions to enter the public domain and serve as the foundation for new developments. Thus, the patent term is not merely a measure of time but a cornerstone of the larger balance that underpins intellectual property law: a balance between rewarding creativity and ensuring societal progress.